圣诺生物
(688117)
| 流通市值：19.22亿 | | | 总市值：32.50亿 |
| 流通股本：6622.14万 | | | 总股本：1.12亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 104,057,251.91 | 435,021,032.33 | 291,226,325.99 | 173,833,824.96 |
| 营业收入 | 104,057,251.91 | 435,021,032.33 | 291,226,325.99 | 173,833,824.96 |
| 二、营业总成本 | 86,932,598.39 | 357,476,689.72 | 254,711,696.95 | 157,568,942.94 |
| 营业成本 | 38,373,417.24 | 157,649,159.41 | 107,761,417.56 | 61,072,942.7 |
| 税金及附加 | 1,324,269.24 | 4,034,079.76 | 2,606,330.49 | 1,827,149.37 |
| 销售费用 | 23,176,474.16 | 107,972,070.62 | 79,664,413.77 | 48,772,002.9 |
| 管理费用 | 12,618,455.3 | 53,862,951.84 | 40,779,789.1 | 30,712,443.22 |
| 研发费用 | 9,416,771.26 | 29,047,663.23 | 20,381,012.27 | 13,178,506.38 |
| 财务费用 | 2,023,211.19 | 4,910,764.86 | 3,518,733.76 | 2,005,898.37 |
| 其中:利息费用 | 2,936,363.16 | 9,264,942.18 | 6,831,606.58 | 4,344,692.3 |
| 其中:利息收入 | 838,481.68 | 3,919,910.51 | 2,729,686.13 | 2,013,586.06 |
| 加:投资收益 | 298,891.63 | -1,420,958.21 | -900,469.16 | -404,080.19 |
| 资产处置收益 | 35 | -1,061.71 | -1,061.71 | -1,061.71 |
| 资产减值损失(新) | -874,479.67 | -4,930,227.92 | -4,264,987.1 | -2,514,117.98 |
| 信用减值损失(新) | 1,431,408.93 | -3,047,193.55 | -593,147.34 | -656,296.99 |
| 其他收益 | 1,607,099.75 | 12,956,194.45 | 11,180,437.83 | 10,740,268.57 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 19,587,609.16 | 81,101,095.67 | 41,935,401.56 | 23,429,593.72 |
| 加:营业外收入 | 21,333.96 | 333,478.55 | 318,486.75 | 247,893.22 |
| 减:营业外支出 | 307,634.57 | 1,313,056.31 | 1,189,776.6 | 893,344.35 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 19,301,308.55 | 80,121,517.91 | 41,064,111.71 | 22,784,142.59 |
| 减:所得税费用 | 2,851,172.56 | 9,797,076.88 | 6,267,874.46 | 2,636,007.71 |
| 六、净利润 | 16,450,135.99 | 70,324,441.03 | 34,796,237.25 | 20,148,134.88 |
| 持续经营净利润 | 16,450,135.99 | 70,324,441.03 | 34,796,237.25 | 20,148,134.88 |
| 归属于母公司股东的净利润 | 16,472,225.12 | 70,337,139.39 | 34,796,237.25 | 20,148,134.88 |
| 少数股东损益 | -22,089.13 | -12,698.36 | - | - |
| (一)基本每股收益 | 0.15 | 0.63 | 0.31 | 0.18 |
| (二)稀释每股收益 | 0.15 | 0.62 | 0.31 | 0.18 |
| 九、综合收益总额 | 16,450,135.99 | 70,324,441.03 | 34,796,237.25 | 20,148,134.88 |
| 归属于母公司股东的综合收益总额 | 16,472,225.12 | 70,337,139.39 | 34,796,237.25 | 20,148,134.88 |
| 归属于少数股东的综合收益总额 | -22,089.13 | -12,698.36 | - | - |
| 公告日期 | 2024-04-23 | 2024-04-23 | 2023-10-31 | 2023-08-18 |
| 审计意见(境内) | | 标准无保留意见 | | |